nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—uterine cervix—fallopian tube cancer	0.186	0.186	CbGeAlD
Tofisopam—PDE2A—uterus—fallopian tube cancer	0.155	0.155	CbGeAlD
Tofisopam—PDE2A—female reproductive system—fallopian tube cancer	0.14	0.14	CbGeAlD
Tofisopam—PDE10A—female gonad—fallopian tube cancer	0.127	0.127	CbGeAlD
Tofisopam—PDE2A—vagina—fallopian tube cancer	0.126	0.126	CbGeAlD
Tofisopam—PDE4A—female gonad—fallopian tube cancer	0.0875	0.0875	CbGeAlD
Tofisopam—PDE3A—female reproductive system—fallopian tube cancer	0.0795	0.0795	CbGeAlD
Tofisopam—PDE3A—female gonad—fallopian tube cancer	0.0724	0.0724	CbGeAlD
Tofisopam—CYP3A4—female reproductive system—fallopian tube cancer	0.0255	0.0255	CbGeAlD
